OctreoPharm Sciences' Acquisition

OctreoPharm Sciences was acquired by Ipsen on May 19, 2015.

OctreoPharm Sciences is a biopharmaceutical company that focuses on the development of new radio pharmaceuticals for neuroendocrine tumours.…

Articles about OctreoPharm Sciences' Acquisition: